Cigna Increases Yearly Profit Outlook Following Strong Quarter

Reuters | April 30, 2026 at 10:12 AM UTC
Bullish 81% Confidence Unanimous Agreement
Read Original Article

Key Points

  • Quarterly medical loss ratio came in at 79.8%, below the analyst estimate of 81.56%, reflecting better cost management and impact of divesting Medicare business to Health Care Service Corp
  • Evernorth health services unit revenue rose nearly 9% to $58.44 billion in the quarter
  • Adjusted earnings of $7.79 per share beat estimates, prompting the company to increase its 2026 full-year profit outlook

AI Summary

Cigna Raises Annual Profit Outlook on Strong Q1 Performance

Key Developments:

Cigna has increased its annual adjusted profit forecast after surpassing first-quarter earnings estimates, driven by strong performance in its health services division and lower-than-expected medical costs.

Financial Performance:

  • Adjusted quarterly earnings: $7.79 per share, beating analyst expectations
  • Medical loss ratio (MLR): 79.8%, significantly better than the 81.56% analyst forecast
  • Evernorth health services revenue: $58.44 billion, up nearly 9% year-over-year

Strategic Positioning:

Unlike competitors, Cigna has exited Medicare Advantage plans for seniors and disabled individuals while scaling back its Affordable Care Act (Obamacare) business. The company now focuses primarily on:

  • Pharmacy benefits management segment
  • Employer-sponsored healthcare plans

The insurer is transitioning select customers to a new pricing model that eliminates after-market rebates, a strategy expected to roll out over the next two years.

Market Context:

The improved MLR reflects the impact of Cigna's agreement with Health Care Service Corp to divest its Medicare business, allowing the company to streamline operations and reduce exposure to higher-cost segments.

Outlook:

Cigna raised its 2026 adjusted profit per share guidance, signaling confidence in its business transformation and operational efficiency gains.

Implications:

The results demonstrate Cigna's successful pivot away from government-sponsored insurance programs toward higher-margin commercial and pharmacy benefits businesses. The better-than-expected MLR suggests effective cost management and favorable claims experience, positioning the company competitively as peers navigate Medicare Advantage challenges.

Model Analysis Breakdown

Model Sentiment Confidence
GPT-5-mini Bullish 80%
Claude 4.5 Haiku Bullish 75%
Gemini 2.5 Flash Bullish 90%
Consensus Bullish 81%